Cadrenal Therapeutics, Inc. — Form D

Cadrenal Therapeutics, Inc. of PONTE VEDRA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-06. The offering totals $7.9M, of which $7.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Jeffrey ColeRelated PersonToronto, A6
JAMES FERGUSONRelated PersonPonte Vedra, FL
Lee GoldenRelated PersonPonte Vedra, FL
John R. MurphyRelated PersonPonte Vedra, FL
Quang X. PhamRelated PersonPonte Vedra, FL
Matthew SzotRelated PersonPonte Vedra, FL
Glynn WilsonRelated PersonPonte Vedra, FL
STEVEN ZELENKOFSKERelated PersonPonte Vedra, FL
JOHN R MURPHYDirectorPONTE VEDRA, FL
LEE S GOLDENDirectorPONTE VEDRA, FL
JEFFREY K COLEExecutive OfficerPONTE VEDRA, FL
QUANG X PHAMDirectorPONTE VEDRA, FL
QUANG X PHAMExecutive OfficerPONTE VEDRA, FL
JAMES J FERGUSONExecutive OfficerPONTE VEDRA, FL
GLYNN J WILSONDirectorPONTE VEDRA, FL
STEVEN J ZELENKOFSKEDirectorPONTE VEDRA, FL
John MurphyDirectorBeaver Falls, PA
Steven W ZelenkofskeDirectorPonte Vedra, FL
Jeff W ColeExecutive OfficerPonte Vedra, FL
Glynn W WilsonDirectorPonte Vedra, FL
Matthew SzotExecutive OfficerPonte Vedra, FL
Douglas W LosordoExecutive OfficerPonte Vedra, FL
Quang PhamDirectorPonte Vedra, FL
Quang PhamExecutive OfficerPonte Vedra, FL
Robert W LisickiDirectorPonte Vedra, FL

Other filings by this issuer (6)

FiledFormOfferingSold
2026-07-15D$8.8M$8.8M
2025-12-31D$4.4M$4.4M
2024-11-14D$9.4M$9.4M
2023-07-18D$7.5M$7.5M
2022-12-08D$1.0M$250K
2022-07-25D$2.0M$150K

More